nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—breast cancer	0.404	0.654	CbGaD
Pseudoephedrine—TNF—breast cancer	0.137	0.221	CbGaD
Pseudoephedrine—CYP2D6—breast cancer	0.0772	0.125	CbGaD
Pseudoephedrine—NFATC1—mammary gland—breast cancer	0.00596	0.113	CbGeAlD
Pseudoephedrine—IL2—epithelium—breast cancer	0.00303	0.0576	CbGeAlD
Pseudoephedrine—IL2—skin of body—breast cancer	0.00289	0.0548	CbGeAlD
Pseudoephedrine—NFATC1—adipose tissue—breast cancer	0.00268	0.0509	CbGeAlD
Pseudoephedrine—IL2—uterus—breast cancer	0.00251	0.0476	CbGeAlD
Pseudoephedrine—NFATC1—adrenal gland—breast cancer	0.0024	0.0457	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—breast cancer	0.00233	0.0442	CbGeAlD
Pseudoephedrine—IL2—female reproductive system—breast cancer	0.00225	0.0428	CbGeAlD
Pseudoephedrine—NFATC1—female gonad—breast cancer	0.00224	0.0426	CbGeAlD
Pseudoephedrine—IL2—bone marrow—breast cancer	0.00213	0.0404	CbGeAlD
Pseudoephedrine—IL2—female gonad—breast cancer	0.00205	0.039	CbGeAlD
Pseudoephedrine—IL2—endocrine gland—breast cancer	0.00191	0.0362	CbGeAlD
Pseudoephedrine—Etomidate—SLC2A1—breast cancer	0.00176	0.452	CrCbGaD
Pseudoephedrine—NFATC1—lymph node—breast cancer	0.00144	0.0274	CbGeAlD
Pseudoephedrine—TNF—lymph node—breast cancer	0.00138	0.0261	CbGeAlD
Pseudoephedrine—IL2—lymph node—breast cancer	0.00132	0.025	CbGeAlD
Pseudoephedrine—MAOA—nipple—breast cancer	0.000885	0.0168	CbGeAlD
Pseudoephedrine—MAOA—embryo—breast cancer	0.00073	0.0139	CbGeAlD
Pseudoephedrine—ADRA2A—nipple—breast cancer	0.000679	0.0129	CbGeAlD
Pseudoephedrine—ADRB1—adipose tissue—breast cancer	0.000615	0.0117	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—breast cancer	0.000601	0.0114	CbGeAlD
Pseudoephedrine—ADRB1—female reproductive system—breast cancer	0.000565	0.0107	CbGeAlD
Pseudoephedrine—SLC6A4—female reproductive system—breast cancer	0.000546	0.0104	CbGeAlD
Pseudoephedrine—MAOA—endometrium—breast cancer	0.000534	0.0102	CbGeAlD
Pseudoephedrine—MAOA—uterus—breast cancer	0.000492	0.00935	CbGeAlD
Pseudoephedrine—ADRA1A—adipose tissue—breast cancer	0.000486	0.00923	CbGeAlD
Pseudoephedrine—MAOA—pituitary gland—breast cancer	0.000484	0.00919	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—breast cancer	0.000482	0.00915	CbGeAlD
Pseudoephedrine—SLC6A2—female reproductive system—breast cancer	0.00048	0.00913	CbGeAlD
Pseudoephedrine—ADRB1—endocrine gland—breast cancer	0.000478	0.00908	CbGeAlD
Pseudoephedrine—SLC6A2—adrenal gland—breast cancer	0.000469	0.00891	CbGeAlD
Pseudoephedrine—SLC6A4—endocrine gland—breast cancer	0.000462	0.00877	CbGeAlD
Pseudoephedrine—MAOA—female reproductive system—breast cancer	0.000443	0.00841	CbGeAlD
Pseudoephedrine—ADRA1A—adrenal gland—breast cancer	0.000436	0.00828	CbGeAlD
Pseudoephedrine—MAOA—adrenal gland—breast cancer	0.000432	0.00821	CbGeAlD
Pseudoephedrine—Ephedrine—ACHE—breast cancer	0.000425	0.11	CrCbGaD
Pseudoephedrine—ADRA2A—endometrium—breast cancer	0.00041	0.00779	CbGeAlD
Pseudoephedrine—SLC6A2—endocrine gland—breast cancer	0.000407	0.00772	CbGeAlD
Pseudoephedrine—MAOA—female gonad—breast cancer	0.000403	0.00765	CbGeAlD
Pseudoephedrine—ADRA1A—endocrine gland—breast cancer	0.000378	0.00718	CbGeAlD
Pseudoephedrine—ADRA2A—uterus—breast cancer	0.000378	0.00718	CbGeAlD
Pseudoephedrine—MAOA—endocrine gland—breast cancer	0.000375	0.00712	CbGeAlD
Pseudoephedrine—ADRA2A—pituitary gland—breast cancer	0.000371	0.00705	CbGeAlD
Pseudoephedrine—ADRA2A—adipose tissue—breast cancer	0.000369	0.00702	CbGeAlD
Pseudoephedrine—ADRA2A—female reproductive system—breast cancer	0.00034	0.00645	CbGeAlD
Pseudoephedrine—ADRA2A—adrenal gland—breast cancer	0.000331	0.0063	CbGeAlD
Pseudoephedrine—Etomidate—CYP19A1—breast cancer	0.000331	0.0852	CrCbGaD
Pseudoephedrine—ADRA2A—female gonad—breast cancer	0.000309	0.00587	CbGeAlD
Pseudoephedrine—ADRA2A—endocrine gland—breast cancer	0.000287	0.00546	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—breast cancer	0.000281	0.00534	CbGeAlD
Pseudoephedrine—CYP2D6—female reproductive system—breast cancer	0.000263	0.005	CbGeAlD
Pseudoephedrine—MAOA—lymph node—breast cancer	0.000259	0.00492	CbGeAlD
Pseudoephedrine—Ephedrine—BCHE—breast cancer	0.00025	0.0644	CrCbGaD
Pseudoephedrine—CYP2D6—female gonad—breast cancer	0.000239	0.00455	CbGeAlD
Pseudoephedrine—CYP2D6—endocrine gland—breast cancer	0.000223	0.00423	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—breast cancer	0.000199	0.00377	CbGeAlD
Pseudoephedrine—Anorexia—Mitoxantrone—breast cancer	0.000157	0.00123	CcSEcCtD
Pseudoephedrine—Anorexia—Irinotecan—breast cancer	0.000157	0.00123	CcSEcCtD
Pseudoephedrine—Nausea—Chlorambucil—breast cancer	0.000156	0.00122	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Gemcitabine—breast cancer	0.000155	0.00122	CcSEcCtD
Pseudoephedrine—Dizziness—Tamoxifen—breast cancer	0.000154	0.00121	CcSEcCtD
Pseudoephedrine—Tremor—Paclitaxel—breast cancer	0.000154	0.00121	CcSEcCtD
Pseudoephedrine—Tachycardia—Fluorouracil—breast cancer	0.000154	0.00121	CcSEcCtD
Pseudoephedrine—Anorexia—Gemcitabine—breast cancer	0.000153	0.0012	CcSEcCtD
Pseudoephedrine—Vomiting—Vinblastine—breast cancer	0.000153	0.0012	CcSEcCtD
Pseudoephedrine—Agitation—Paclitaxel—breast cancer	0.000151	0.00119	CcSEcCtD
Pseudoephedrine—Body temperature increased—Thiotepa—breast cancer	0.000151	0.00119	CcSEcCtD
Pseudoephedrine—Headache—Vinblastine—breast cancer	0.000151	0.00118	CcSEcCtD
Pseudoephedrine—Anorexia—Fluorouracil—breast cancer	0.00015	0.00118	CcSEcCtD
Pseudoephedrine—Insomnia—Irinotecan—breast cancer	0.000149	0.00117	CcSEcCtD
Pseudoephedrine—Vomiting—Tamoxifen—breast cancer	0.000149	0.00117	CcSEcCtD
Pseudoephedrine—Vertigo—Paclitaxel—breast cancer	0.000148	0.00116	CcSEcCtD
Pseudoephedrine—Dizziness—Goserelin—breast cancer	0.000148	0.00116	CcSEcCtD
Pseudoephedrine—Rash—Tamoxifen—breast cancer	0.000147	0.00116	CcSEcCtD
Pseudoephedrine—Dermatitis—Tamoxifen—breast cancer	0.000147	0.00116	CcSEcCtD
Pseudoephedrine—Dyspnoea—Irinotecan—breast cancer	0.000147	0.00115	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mitoxantrone—breast cancer	0.000147	0.00115	CcSEcCtD
Pseudoephedrine—Headache—Tamoxifen—breast cancer	0.000146	0.00115	CcSEcCtD
Pseudoephedrine—Palpitations—Paclitaxel—breast cancer	0.000146	0.00114	CcSEcCtD
Pseudoephedrine—Vomiting—Melphalan—breast cancer	0.000145	0.00114	CcSEcCtD
Pseudoephedrine—Insomnia—Gemcitabine—breast cancer	0.000145	0.00114	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mitoxantrone—breast cancer	0.000145	0.00114	CcSEcCtD
Pseudoephedrine—Dyspepsia—Irinotecan—breast cancer	0.000145	0.00114	CcSEcCtD
Pseudoephedrine—Rash—Melphalan—breast cancer	0.000144	0.00113	CcSEcCtD
Pseudoephedrine—Dermatitis—Melphalan—breast cancer	0.000144	0.00113	CcSEcCtD
Pseudoephedrine—Asthenia—Vinorelbine—breast cancer	0.000143	0.00113	CcSEcCtD
Pseudoephedrine—Decreased appetite—Irinotecan—breast cancer	0.000143	0.00113	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mitoxantrone—breast cancer	0.000143	0.00113	CcSEcCtD
Pseudoephedrine—Arrhythmia—Docetaxel—breast cancer	0.000143	0.00113	CcSEcCtD
Pseudoephedrine—Dyspnoea—Gemcitabine—breast cancer	0.000143	0.00112	CcSEcCtD
Pseudoephedrine—Nausea—Vinblastine—breast cancer	0.000143	0.00112	CcSEcCtD
Pseudoephedrine—Insomnia—Fluorouracil—breast cancer	0.000143	0.00112	CcSEcCtD
Pseudoephedrine—Hypertension—Paclitaxel—breast cancer	0.000142	0.00112	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A1—breast cancer	0.000142	0.0366	CrCbGaD
Pseudoephedrine—Vomiting—Goserelin—breast cancer	0.000142	0.00111	CcSEcCtD
Pseudoephedrine—Pain—Irinotecan—breast cancer	0.000141	0.00111	CcSEcCtD
Pseudoephedrine—Pain—Mitoxantrone—breast cancer	0.000141	0.00111	CcSEcCtD
Pseudoephedrine—Dyspnoea—Fluorouracil—breast cancer	0.000141	0.00111	CcSEcCtD
Pseudoephedrine—Rash—Goserelin—breast cancer	0.000141	0.00111	CcSEcCtD
Pseudoephedrine—Dermatitis—Goserelin—breast cancer	0.000141	0.0011	CcSEcCtD
Pseudoephedrine—Chest pain—Paclitaxel—breast cancer	0.00014	0.0011	CcSEcCtD
Pseudoephedrine—Headache—Goserelin—breast cancer	0.00014	0.0011	CcSEcCtD
Pseudoephedrine—Anxiety—Paclitaxel—breast cancer	0.00014	0.0011	CcSEcCtD
Pseudoephedrine—Decreased appetite—Gemcitabine—breast cancer	0.00014	0.0011	CcSEcCtD
Pseudoephedrine—Dyspepsia—Fluorouracil—breast cancer	0.000139	0.00109	CcSEcCtD
Pseudoephedrine—Nausea—Tamoxifen—breast cancer	0.000139	0.00109	CcSEcCtD
Pseudoephedrine—Arrhythmia—Capecitabine—breast cancer	0.000139	0.00109	CcSEcCtD
Pseudoephedrine—Pain—Gemcitabine—breast cancer	0.000137	0.00108	CcSEcCtD
Pseudoephedrine—Decreased appetite—Fluorouracil—breast cancer	0.000137	0.00108	CcSEcCtD
Pseudoephedrine—Asthenia—Thiotepa—breast cancer	0.000137	0.00108	CcSEcCtD
Pseudoephedrine—Nausea—Melphalan—breast cancer	0.000136	0.00107	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mitoxantrone—breast cancer	0.000136	0.00107	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Irinotecan—breast cancer	0.000136	0.00107	CcSEcCtD
Pseudoephedrine—Confusional state—Paclitaxel—breast cancer	0.000136	0.00106	CcSEcCtD
Pseudoephedrine—Dysuria—Methotrexate—breast cancer	0.000135	0.00106	CcSEcCtD
Pseudoephedrine—Pain—Fluorouracil—breast cancer	0.000135	0.00106	CcSEcCtD
Pseudoephedrine—Muscle spasms—Docetaxel—breast cancer	0.000134	0.00105	CcSEcCtD
Pseudoephedrine—Nausea—Goserelin—breast cancer	0.000133	0.00104	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Gemcitabine—breast cancer	0.000132	0.00104	CcSEcCtD
Pseudoephedrine—Dizziness—Vinorelbine—breast cancer	0.000132	0.00104	CcSEcCtD
Pseudoephedrine—Angina pectoris—Epirubicin—breast cancer	0.000132	0.00103	CcSEcCtD
Pseudoephedrine—Tachycardia—Paclitaxel—breast cancer	0.000131	0.00103	CcSEcCtD
Pseudoephedrine—Body temperature increased—Irinotecan—breast cancer	0.00013	0.00102	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mitoxantrone—breast cancer	0.00013	0.00102	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Fluorouracil—breast cancer	0.00013	0.00102	CcSEcCtD
Pseudoephedrine—Muscle spasms—Capecitabine—breast cancer	0.00013	0.00102	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Paclitaxel—breast cancer	0.00013	0.00102	CcSEcCtD
Pseudoephedrine—Anorexia—Paclitaxel—breast cancer	0.000128	0.00101	CcSEcCtD
Pseudoephedrine—Vomiting—Vinorelbine—breast cancer	0.000127	0.000998	CcSEcCtD
Pseudoephedrine—Body temperature increased—Gemcitabine—breast cancer	0.000127	0.000997	CcSEcCtD
Pseudoephedrine—Tremor—Capecitabine—breast cancer	0.000127	0.000995	CcSEcCtD
Pseudoephedrine—Dysuria—Epirubicin—breast cancer	0.000126	0.000993	CcSEcCtD
Pseudoephedrine—Dizziness—Thiotepa—breast cancer	0.000126	0.000992	CcSEcCtD
Pseudoephedrine—Rash—Vinorelbine—breast cancer	0.000126	0.00099	CcSEcCtD
Pseudoephedrine—Dermatitis—Vinorelbine—breast cancer	0.000126	0.000989	CcSEcCtD
Pseudoephedrine—Headache—Vinorelbine—breast cancer	0.000125	0.000984	CcSEcCtD
Pseudoephedrine—Body temperature increased—Fluorouracil—breast cancer	0.000125	0.00098	CcSEcCtD
Pseudoephedrine—Sweating—Methotrexate—breast cancer	0.000123	0.00097	CcSEcCtD
Pseudoephedrine—Palpitations—Docetaxel—breast cancer	0.000123	0.000969	CcSEcCtD
Pseudoephedrine—Angina pectoris—Doxorubicin—breast cancer	0.000122	0.000957	CcSEcCtD
Pseudoephedrine—Insomnia—Paclitaxel—breast cancer	0.000122	0.000955	CcSEcCtD
Pseudoephedrine—Vertigo—Capecitabine—breast cancer	0.000121	0.000954	CcSEcCtD
Pseudoephedrine—Vomiting—Thiotepa—breast cancer	0.000121	0.000953	CcSEcCtD
Pseudoephedrine—Hypertension—Docetaxel—breast cancer	0.000121	0.000947	CcSEcCtD
Pseudoephedrine—Rash—Thiotepa—breast cancer	0.00012	0.000945	CcSEcCtD
Pseudoephedrine—Dermatitis—Thiotepa—breast cancer	0.00012	0.000945	CcSEcCtD
Pseudoephedrine—Dyspnoea—Paclitaxel—breast cancer	0.00012	0.000942	CcSEcCtD
Pseudoephedrine—Headache—Thiotepa—breast cancer	0.00012	0.000939	CcSEcCtD
Pseudoephedrine—Palpitations—Capecitabine—breast cancer	0.000119	0.000938	CcSEcCtD
Pseudoephedrine—Chest pain—Docetaxel—breast cancer	0.000119	0.000934	CcSEcCtD
Pseudoephedrine—Nausea—Vinorelbine—breast cancer	0.000119	0.000933	CcSEcCtD
Pseudoephedrine—Dyspepsia—Paclitaxel—breast cancer	0.000118	0.00093	CcSEcCtD
Pseudoephedrine—Asthenia—Mitoxantrone—breast cancer	0.000118	0.000929	CcSEcCtD
Pseudoephedrine—Asthenia—Irinotecan—breast cancer	0.000118	0.000929	CcSEcCtD
Pseudoephedrine—Dysuria—Doxorubicin—breast cancer	0.000117	0.000919	CcSEcCtD
Pseudoephedrine—Decreased appetite—Paclitaxel—breast cancer	0.000117	0.000918	CcSEcCtD
Pseudoephedrine—Hypertension—Capecitabine—breast cancer	0.000117	0.000917	CcSEcCtD
Pseudoephedrine—Sweating—Epirubicin—breast cancer	0.000116	0.000908	CcSEcCtD
Pseudoephedrine—Asthenia—Gemcitabine—breast cancer	0.000115	0.000905	CcSEcCtD
Pseudoephedrine—Chest pain—Capecitabine—breast cancer	0.000115	0.000904	CcSEcCtD
Pseudoephedrine—Pain—Paclitaxel—breast cancer	0.000115	0.000903	CcSEcCtD
Pseudoephedrine—Confusional state—Docetaxel—breast cancer	0.000115	0.000903	CcSEcCtD
Pseudoephedrine—Anxiety—Capecitabine—breast cancer	0.000115	0.000901	CcSEcCtD
Pseudoephedrine—Nausea—Thiotepa—breast cancer	0.000113	0.000891	CcSEcCtD
Pseudoephedrine—Confusional state—Capecitabine—breast cancer	0.000111	0.000874	CcSEcCtD
Pseudoephedrine—Tachycardia—Docetaxel—breast cancer	0.000111	0.000874	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Paclitaxel—breast cancer	0.000111	0.00087	CcSEcCtD
Pseudoephedrine—Bradycardia—Epirubicin—breast cancer	0.00011	0.000865	CcSEcCtD
Pseudoephedrine—Phentermine—CYP2D6—breast cancer	0.00011	0.0283	CrCbGaD
Pseudoephedrine—Dizziness—Irinotecan—breast cancer	0.000109	0.000856	CcSEcCtD
Pseudoephedrine—Anorexia—Docetaxel—breast cancer	0.000109	0.000853	CcSEcCtD
Pseudoephedrine—Tachycardia—Capecitabine—breast cancer	0.000108	0.000846	CcSEcCtD
Pseudoephedrine—Sweating—Doxorubicin—breast cancer	0.000107	0.00084	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Capecitabine—breast cancer	0.000107	0.000838	CcSEcCtD
Pseudoephedrine—Body temperature increased—Paclitaxel—breast cancer	0.000106	0.000835	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP2D6—breast cancer	0.000106	0.0272	CrCbGaD
Pseudoephedrine—Anorexia—Capecitabine—breast cancer	0.000105	0.000826	CcSEcCtD
Pseudoephedrine—Vomiting—Irinotecan—breast cancer	0.000105	0.000823	CcSEcCtD
Pseudoephedrine—Vomiting—Mitoxantrone—breast cancer	0.000105	0.000823	CcSEcCtD
Pseudoephedrine—Dextroamphetamine—CYP2D6—breast cancer	0.000105	0.027	CrCbGaD
Pseudoephedrine—Dizziness—Fluorouracil—breast cancer	0.000104	0.00082	CcSEcCtD
Pseudoephedrine—Rash—Irinotecan—breast cancer	0.000104	0.000816	CcSEcCtD
Pseudoephedrine—Rash—Mitoxantrone—breast cancer	0.000104	0.000816	CcSEcCtD
Pseudoephedrine—Dermatitis—Mitoxantrone—breast cancer	0.000104	0.000816	CcSEcCtD
Pseudoephedrine—Dermatitis—Irinotecan—breast cancer	0.000104	0.000816	CcSEcCtD
Pseudoephedrine—Headache—Irinotecan—breast cancer	0.000103	0.000811	CcSEcCtD
Pseudoephedrine—Headache—Mitoxantrone—breast cancer	0.000103	0.000811	CcSEcCtD
Pseudoephedrine—Insomnia—Docetaxel—breast cancer	0.000103	0.00081	CcSEcCtD
Pseudoephedrine—Vomiting—Gemcitabine—breast cancer	0.000102	0.000802	CcSEcCtD
Pseudoephedrine—Bradycardia—Doxorubicin—breast cancer	0.000102	0.0008	CcSEcCtD
Pseudoephedrine—Dyspnoea—Docetaxel—breast cancer	0.000102	0.000798	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2D6—breast cancer	0.000101	0.0261	CrCbGaD
Pseudoephedrine—Rash—Gemcitabine—breast cancer	0.000101	0.000795	CcSEcCtD
Pseudoephedrine—Dermatitis—Gemcitabine—breast cancer	0.000101	0.000795	CcSEcCtD
Pseudoephedrine—Headache—Gemcitabine—breast cancer	0.000101	0.00079	CcSEcCtD
Pseudoephedrine—Vomiting—Fluorouracil—breast cancer	0.0001	0.000789	CcSEcCtD
Pseudoephedrine—Dyspepsia—Docetaxel—breast cancer	0.0001	0.000788	CcSEcCtD
Pseudoephedrine—Insomnia—Capecitabine—breast cancer	9.98e-05	0.000784	CcSEcCtD
Pseudoephedrine—Rash—Fluorouracil—breast cancer	9.95e-05	0.000782	CcSEcCtD
Pseudoephedrine—Dermatitis—Fluorouracil—breast cancer	9.94e-05	0.000781	CcSEcCtD
Pseudoephedrine—Decreased appetite—Docetaxel—breast cancer	9.9e-05	0.000778	CcSEcCtD
Pseudoephedrine—Headache—Fluorouracil—breast cancer	9.89e-05	0.000777	CcSEcCtD
Pseudoephedrine—Dyspnoea—Capecitabine—breast cancer	9.83e-05	0.000773	CcSEcCtD
Pseudoephedrine—Nausea—Mitoxantrone—breast cancer	9.79e-05	0.000769	CcSEcCtD
Pseudoephedrine—Nausea—Irinotecan—breast cancer	9.79e-05	0.000769	CcSEcCtD
Pseudoephedrine—Pain—Docetaxel—breast cancer	9.74e-05	0.000765	CcSEcCtD
Pseudoephedrine—Dyspepsia—Capecitabine—breast cancer	9.71e-05	0.000763	CcSEcCtD
Pseudoephedrine—Arrhythmia—Epirubicin—breast cancer	9.66e-05	0.000759	CcSEcCtD
Pseudoephedrine—Asthenia—Paclitaxel—breast cancer	9.64e-05	0.000758	CcSEcCtD
Pseudoephedrine—Decreased appetite—Capecitabine—breast cancer	9.59e-05	0.000753	CcSEcCtD
Pseudoephedrine—Nausea—Gemcitabine—breast cancer	9.54e-05	0.000749	CcSEcCtD
Pseudoephedrine—Pain—Capecitabine—breast cancer	9.43e-05	0.000741	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Docetaxel—breast cancer	9.39e-05	0.000738	CcSEcCtD
Pseudoephedrine—Nausea—Fluorouracil—breast cancer	9.38e-05	0.000737	CcSEcCtD
Pseudoephedrine—Tension—Epirubicin—breast cancer	9.24e-05	0.000726	CcSEcCtD
Pseudoephedrine—Nervousness—Epirubicin—breast cancer	9.14e-05	0.000718	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Capecitabine—breast cancer	9.09e-05	0.000714	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP3A4—breast cancer	9.07e-05	0.0234	CrCbGaD
Pseudoephedrine—Muscle spasms—Epirubicin—breast cancer	9.05e-05	0.000711	CcSEcCtD
Pseudoephedrine—Vertigo—Methotrexate—breast cancer	9.04e-05	0.00071	CcSEcCtD
Pseudoephedrine—Body temperature increased—Docetaxel—breast cancer	9.01e-05	0.000708	CcSEcCtD
Pseudoephedrine—Arrhythmia—Doxorubicin—breast cancer	8.94e-05	0.000702	CcSEcCtD
Pseudoephedrine—Dizziness—Paclitaxel—breast cancer	8.89e-05	0.000698	CcSEcCtD
Pseudoephedrine—Body temperature increased—Capecitabine—breast cancer	8.72e-05	0.000685	CcSEcCtD
Pseudoephedrine—Selegiline—CYP3A4—breast cancer	8.7e-05	0.0224	CrCbGaD
Pseudoephedrine—Agitation—Epirubicin—breast cancer	8.65e-05	0.00068	CcSEcCtD
Pseudoephedrine—Chest pain—Methotrexate—breast cancer	8.57e-05	0.000673	CcSEcCtD
Pseudoephedrine—Tension—Doxorubicin—breast cancer	8.55e-05	0.000672	CcSEcCtD
Pseudoephedrine—Vomiting—Paclitaxel—breast cancer	8.55e-05	0.000671	CcSEcCtD
Pseudoephedrine—Rash—Paclitaxel—breast cancer	8.47e-05	0.000666	CcSEcCtD
Pseudoephedrine—Dermatitis—Paclitaxel—breast cancer	8.47e-05	0.000665	CcSEcCtD
Pseudoephedrine—Nervousness—Doxorubicin—breast cancer	8.46e-05	0.000665	CcSEcCtD
Pseudoephedrine—Vertigo—Epirubicin—breast cancer	8.46e-05	0.000665	CcSEcCtD
Pseudoephedrine—Amphetamine—CYP2D6—breast cancer	8.43e-05	0.0217	CrCbGaD
Pseudoephedrine—Headache—Paclitaxel—breast cancer	8.42e-05	0.000662	CcSEcCtD
Pseudoephedrine—Muscle spasms—Doxorubicin—breast cancer	8.38e-05	0.000658	CcSEcCtD
Pseudoephedrine—Palpitations—Epirubicin—breast cancer	8.32e-05	0.000654	CcSEcCtD
Pseudoephedrine—Confusional state—Methotrexate—breast cancer	8.28e-05	0.000651	CcSEcCtD
Pseudoephedrine—Asthenia—Docetaxel—breast cancer	8.17e-05	0.000642	CcSEcCtD
Pseudoephedrine—Hypertension—Epirubicin—breast cancer	8.13e-05	0.000639	CcSEcCtD
Pseudoephedrine—Chest pain—Epirubicin—breast cancer	8.02e-05	0.00063	CcSEcCtD
Pseudoephedrine—Agitation—Doxorubicin—breast cancer	8.01e-05	0.000629	CcSEcCtD
Pseudoephedrine—Anxiety—Epirubicin—breast cancer	7.99e-05	0.000628	CcSEcCtD
Pseudoephedrine—Nausea—Paclitaxel—breast cancer	7.98e-05	0.000627	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methotrexate—breast cancer	7.94e-05	0.000624	CcSEcCtD
Pseudoephedrine—Asthenia—Capecitabine—breast cancer	7.91e-05	0.000622	CcSEcCtD
Pseudoephedrine—Vertigo—Doxorubicin—breast cancer	7.83e-05	0.000615	CcSEcCtD
Pseudoephedrine—Anorexia—Methotrexate—breast cancer	7.83e-05	0.000615	CcSEcCtD
Pseudoephedrine—Methamphetamine—CYP2D6—breast cancer	7.81e-05	0.0201	CrCbGaD
Pseudoephedrine—Confusional state—Epirubicin—breast cancer	7.75e-05	0.000609	CcSEcCtD
Pseudoephedrine—Palpitations—Doxorubicin—breast cancer	7.7e-05	0.000605	CcSEcCtD
Pseudoephedrine—Atomoxetine—CYP2D6—breast cancer	7.69e-05	0.0198	CrCbGaD
Pseudoephedrine—Dizziness—Docetaxel—breast cancer	7.53e-05	0.000592	CcSEcCtD
Pseudoephedrine—Hypertension—Doxorubicin—breast cancer	7.52e-05	0.000591	CcSEcCtD
Pseudoephedrine—Tachycardia—Epirubicin—breast cancer	7.5e-05	0.000589	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Epirubicin—breast cancer	7.43e-05	0.000584	CcSEcCtD
Pseudoephedrine—Insomnia—Methotrexate—breast cancer	7.43e-05	0.000584	CcSEcCtD
Pseudoephedrine—Chest pain—Doxorubicin—breast cancer	7.42e-05	0.000583	CcSEcCtD
Pseudoephedrine—Anxiety—Doxorubicin—breast cancer	7.39e-05	0.000581	CcSEcCtD
Pseudoephedrine—Anorexia—Epirubicin—breast cancer	7.32e-05	0.000575	CcSEcCtD
Pseudoephedrine—Dyspnoea—Methotrexate—breast cancer	7.32e-05	0.000575	CcSEcCtD
Pseudoephedrine—Dizziness—Capecitabine—breast cancer	7.29e-05	0.000573	CcSEcCtD
Pseudoephedrine—Selegiline—ABCB1—breast cancer	7.25e-05	0.0187	CrCbGaD
Pseudoephedrine—Vomiting—Docetaxel—breast cancer	7.24e-05	0.000569	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methotrexate—breast cancer	7.23e-05	0.000568	CcSEcCtD
Pseudoephedrine—Rash—Docetaxel—breast cancer	7.18e-05	0.000564	CcSEcCtD
Pseudoephedrine—Dermatitis—Docetaxel—breast cancer	7.18e-05	0.000564	CcSEcCtD
Pseudoephedrine—Confusional state—Doxorubicin—breast cancer	7.17e-05	0.000563	CcSEcCtD
Pseudoephedrine—Decreased appetite—Methotrexate—breast cancer	7.14e-05	0.000561	CcSEcCtD
Pseudoephedrine—Headache—Docetaxel—breast cancer	7.14e-05	0.000561	CcSEcCtD
Pseudoephedrine—Pain—Methotrexate—breast cancer	7.02e-05	0.000552	CcSEcCtD
Pseudoephedrine—Vomiting—Capecitabine—breast cancer	7.01e-05	0.000551	CcSEcCtD
Pseudoephedrine—Rash—Capecitabine—breast cancer	6.95e-05	0.000546	CcSEcCtD
Pseudoephedrine—Insomnia—Epirubicin—breast cancer	6.95e-05	0.000546	CcSEcCtD
Pseudoephedrine—Dermatitis—Capecitabine—breast cancer	6.95e-05	0.000546	CcSEcCtD
Pseudoephedrine—Tachycardia—Doxorubicin—breast cancer	6.94e-05	0.000545	CcSEcCtD
Pseudoephedrine—Headache—Capecitabine—breast cancer	6.91e-05	0.000543	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Doxorubicin—breast cancer	6.87e-05	0.00054	CcSEcCtD
Pseudoephedrine—Dyspnoea—Epirubicin—breast cancer	6.85e-05	0.000538	CcSEcCtD
Pseudoephedrine—Anorexia—Doxorubicin—breast cancer	6.78e-05	0.000532	CcSEcCtD
Pseudoephedrine—Nausea—Docetaxel—breast cancer	6.77e-05	0.000532	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methotrexate—breast cancer	6.77e-05	0.000532	CcSEcCtD
Pseudoephedrine—Dyspepsia—Epirubicin—breast cancer	6.76e-05	0.000531	CcSEcCtD
Pseudoephedrine—Decreased appetite—Epirubicin—breast cancer	6.68e-05	0.000525	CcSEcCtD
Pseudoephedrine—Atomoxetine—CYP3A4—breast cancer	6.6e-05	0.017	CrCbGaD
Pseudoephedrine—Pain—Epirubicin—breast cancer	6.57e-05	0.000516	CcSEcCtD
Pseudoephedrine—Nausea—Capecitabine—breast cancer	6.55e-05	0.000515	CcSEcCtD
Pseudoephedrine—Body temperature increased—Methotrexate—breast cancer	6.49e-05	0.00051	CcSEcCtD
Pseudoephedrine—Insomnia—Doxorubicin—breast cancer	6.43e-05	0.000505	CcSEcCtD
Pseudoephedrine—Dyspnoea—Doxorubicin—breast cancer	6.34e-05	0.000498	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Epirubicin—breast cancer	6.33e-05	0.000498	CcSEcCtD
Pseudoephedrine—Dyspepsia—Doxorubicin—breast cancer	6.26e-05	0.000492	CcSEcCtD
Pseudoephedrine—Decreased appetite—Doxorubicin—breast cancer	6.18e-05	0.000486	CcSEcCtD
Pseudoephedrine—Pain—Doxorubicin—breast cancer	6.08e-05	0.000478	CcSEcCtD
Pseudoephedrine—Body temperature increased—Epirubicin—breast cancer	6.07e-05	0.000477	CcSEcCtD
Pseudoephedrine—Asthenia—Methotrexate—breast cancer	5.89e-05	0.000463	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Doxorubicin—breast cancer	5.86e-05	0.00046	CcSEcCtD
Pseudoephedrine—Body temperature increased—Doxorubicin—breast cancer	5.62e-05	0.000442	CcSEcCtD
Pseudoephedrine—Asthenia—Epirubicin—breast cancer	5.51e-05	0.000433	CcSEcCtD
Pseudoephedrine—Dizziness—Methotrexate—breast cancer	5.43e-05	0.000427	CcSEcCtD
Pseudoephedrine—Vomiting—Methotrexate—breast cancer	5.22e-05	0.00041	CcSEcCtD
Pseudoephedrine—Rash—Methotrexate—breast cancer	5.18e-05	0.000407	CcSEcCtD
Pseudoephedrine—Dermatitis—Methotrexate—breast cancer	5.17e-05	0.000406	CcSEcCtD
Pseudoephedrine—Headache—Methotrexate—breast cancer	5.14e-05	0.000404	CcSEcCtD
Pseudoephedrine—Asthenia—Doxorubicin—breast cancer	5.1e-05	0.000401	CcSEcCtD
Pseudoephedrine—Dizziness—Epirubicin—breast cancer	5.08e-05	0.000399	CcSEcCtD
Pseudoephedrine—Vomiting—Epirubicin—breast cancer	4.89e-05	0.000384	CcSEcCtD
Pseudoephedrine—Nausea—Methotrexate—breast cancer	4.88e-05	0.000383	CcSEcCtD
Pseudoephedrine—Rash—Epirubicin—breast cancer	4.84e-05	0.000381	CcSEcCtD
Pseudoephedrine—Dermatitis—Epirubicin—breast cancer	4.84e-05	0.00038	CcSEcCtD
Pseudoephedrine—Headache—Epirubicin—breast cancer	4.81e-05	0.000378	CcSEcCtD
Pseudoephedrine—Dizziness—Doxorubicin—breast cancer	4.7e-05	0.000369	CcSEcCtD
Pseudoephedrine—Nausea—Epirubicin—breast cancer	4.56e-05	0.000359	CcSEcCtD
Pseudoephedrine—Vomiting—Doxorubicin—breast cancer	4.52e-05	0.000355	CcSEcCtD
Pseudoephedrine—Rash—Doxorubicin—breast cancer	4.48e-05	0.000352	CcSEcCtD
Pseudoephedrine—Dermatitis—Doxorubicin—breast cancer	4.48e-05	0.000352	CcSEcCtD
Pseudoephedrine—Headache—Doxorubicin—breast cancer	4.45e-05	0.00035	CcSEcCtD
Pseudoephedrine—Nausea—Doxorubicin—breast cancer	4.22e-05	0.000332	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—NCOA1—breast cancer	2.17e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—breast cancer	2.17e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BRAF—breast cancer	2.16e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—breast cancer	2.16e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—MAPK3—breast cancer	2.16e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	2.15e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB3—breast cancer	2.14e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR2—breast cancer	2.14e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—STK11—breast cancer	2.13e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.13e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BRAF—breast cancer	2.12e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	2.11e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—breast cancer	2.11e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT2—breast cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—breast cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CG—breast cancer	2.07e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—breast cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—breast cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—breast cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT2—breast cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TERT—breast cancer	2.05e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—breast cancer	2.05e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—breast cancer	2.05e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CAV1—breast cancer	2.04e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CD—breast cancer	2.02e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—breast cancer	2.02e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	2e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—breast cancer	2e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR1—breast cancer	1.99e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—breast cancer	1.98e-06	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.98e-06	9.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CD—breast cancer	1.98e-06	9.98e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—breast cancer	1.98e-06	9.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—breast cancer	1.97e-06	9.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—breast cancer	1.96e-06	9.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.96e-06	9.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—breast cancer	1.96e-06	9.87e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—breast cancer	1.95e-06	9.83e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—breast cancer	1.95e-06	9.82e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FN1—breast cancer	1.94e-06	9.81e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ITPR1—breast cancer	1.94e-06	9.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—breast cancer	1.94e-06	9.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	1.92e-06	9.69e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—breast cancer	1.92e-06	9.67e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—breast cancer	1.91e-06	9.63e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	1.9e-06	9.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CAV1—breast cancer	1.9e-06	9.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—breast cancer	1.88e-06	9.47e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCB1—breast cancer	1.87e-06	9.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—breast cancer	1.87e-06	9.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	1.86e-06	9.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APC—breast cancer	1.86e-06	9.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KIT—breast cancer	1.86e-06	9.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGF—breast cancer	1.84e-06	9.28e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TYMS—breast cancer	1.84e-06	9.26e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—breast cancer	1.83e-06	9.23e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	1.82e-06	9.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CD—breast cancer	1.82e-06	9.17e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.81e-06	9.16e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NCOR1—breast cancer	1.81e-06	9.16e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—breast cancer	1.81e-06	9.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—breast cancer	1.81e-06	9.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FN1—breast cancer	1.81e-06	9.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAF1—breast cancer	1.81e-06	9.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—breast cancer	1.8e-06	9.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—breast cancer	1.79e-06	9.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—breast cancer	1.79e-06	9.01e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	1.79e-06	9.01e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	1.78e-06	8.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	1.78e-06	8.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—breast cancer	1.77e-06	8.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	1.77e-06	8.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAF1—breast cancer	1.77e-06	8.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTOR—breast cancer	1.76e-06	8.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.76e-06	8.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—breast cancer	1.76e-06	8.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BRAF—breast cancer	1.75e-06	8.83e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—breast cancer	1.75e-06	8.81e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—breast cancer	1.74e-06	8.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APC—breast cancer	1.73e-06	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	1.73e-06	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KIT—breast cancer	1.73e-06	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTOR—breast cancer	1.72e-06	8.7e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CB—breast cancer	1.72e-06	8.7e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.72e-06	8.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—breast cancer	1.72e-06	8.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGF—breast cancer	1.71e-06	8.62e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ERCC2—breast cancer	1.71e-06	8.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—breast cancer	1.7e-06	8.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT2—breast cancer	1.7e-06	8.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	1.7e-06	8.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.69e-06	8.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.68e-06	8.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.66e-06	8.36e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	1.66e-06	8.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.65e-06	8.34e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.65e-06	8.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.64e-06	8.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	1.64e-06	8.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BRAF—breast cancer	1.63e-06	8.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—breast cancer	1.62e-06	8.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	1.62e-06	8.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—breast cancer	1.62e-06	8.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	1.62e-06	8.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.62e-06	8.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—breast cancer	1.61e-06	8.12e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—breast cancer	1.6e-06	8.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	1.6e-06	8.08e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.6e-06	8.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—breast cancer	1.59e-06	8e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CB—breast cancer	1.58e-06	7.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—breast cancer	1.58e-06	7.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—breast cancer	1.58e-06	7.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT2—breast cancer	1.58e-06	7.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—breast cancer	1.58e-06	7.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—breast cancer	1.58e-06	7.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	1.58e-06	7.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUN—breast cancer	1.57e-06	7.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—breast cancer	1.57e-06	7.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.56e-06	7.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.55e-06	7.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—breast cancer	1.54e-06	7.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUN—breast cancer	1.54e-06	7.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—breast cancer	1.53e-06	7.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.53e-06	7.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.53e-06	7.7e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—breast cancer	1.52e-06	7.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.52e-06	7.67e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.51e-06	7.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.5e-06	7.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—breast cancer	1.5e-06	7.56e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.49e-06	7.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.49e-06	7.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—breast cancer	1.49e-06	7.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.49e-06	7.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.49e-06	7.5e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAV1—breast cancer	1.48e-06	7.46e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.47e-06	7.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.47e-06	7.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.46e-06	7.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.46e-06	7.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—breast cancer	1.45e-06	7.34e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.45e-06	7.33e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CA—breast cancer	1.45e-06	7.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.45e-06	7.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.44e-06	7.24e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.43e-06	7.19e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.43e-06	7.19e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—breast cancer	1.41e-06	7.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—breast cancer	1.38e-06	6.97e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.38e-06	6.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.37e-06	6.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—breast cancer	1.37e-06	6.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.37e-06	6.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—breast cancer	1.36e-06	6.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.36e-06	6.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.36e-06	6.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.36e-06	6.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.35e-06	6.82e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.35e-06	6.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.35e-06	6.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.34e-06	6.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.34e-06	6.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—breast cancer	1.33e-06	6.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.33e-06	6.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.33e-06	6.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.32e-06	6.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.31e-06	6.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.31e-06	6.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.3e-06	6.57e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.3e-06	6.56e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.28e-06	6.44e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.27e-06	6.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.27e-06	6.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.27e-06	6.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—breast cancer	1.27e-06	6.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.27e-06	6.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.26e-06	6.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.26e-06	6.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.24e-06	6.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.24e-06	6.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—breast cancer	1.24e-06	6.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—breast cancer	1.24e-06	6.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.24e-06	6.23e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.24e-06	6.23e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.23e-06	6.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.23e-06	6.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.22e-06	6.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.22e-06	6.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—breast cancer	1.21e-06	6.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.21e-06	6.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.21e-06	6.08e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.2e-06	6.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.19e-06	5.98e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.18e-06	5.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.18e-06	5.97e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—breast cancer	1.18e-06	5.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.17e-06	5.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—breast cancer	1.17e-06	5.9e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—breast cancer	1.17e-06	5.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.15e-06	5.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.15e-06	5.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.15e-06	5.78e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—breast cancer	1.14e-06	5.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.14e-06	5.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.12e-06	5.65e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—breast cancer	1.12e-06	5.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.12e-06	5.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.11e-06	5.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.1e-06	5.56e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.07e-06	5.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.06e-06	5.36e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.05e-06	5.31e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.05e-06	5.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—breast cancer	1.04e-06	5.24e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.03e-06	5.22e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.03e-06	5.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.02e-06	5.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.02e-06	5.17e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—breast cancer	1.02e-06	5.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.02e-06	5.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—breast cancer	1.02e-06	5.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1e-06	5.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—breast cancer	9.94e-07	5.01e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	9.78e-07	4.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—breast cancer	9.72e-07	4.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CA—breast cancer	9.66e-07	4.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—breast cancer	9.52e-07	4.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—breast cancer	9.51e-07	4.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	9.49e-07	4.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—breast cancer	9.46e-07	4.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—breast cancer	9.31e-07	4.7e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—breast cancer	9.31e-07	4.7e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—breast cancer	8.92e-07	4.5e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—breast cancer	8.79e-07	4.44e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—breast cancer	8.78e-07	4.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	8.69e-07	4.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—breast cancer	8.59e-07	4.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—breast cancer	8.41e-07	4.24e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	8.08e-07	4.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—breast cancer	8.04e-07	4.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—breast cancer	7.89e-07	3.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—breast cancer	7.81e-07	3.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—breast cancer	7.7e-07	3.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—breast cancer	7.47e-07	3.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—breast cancer	7.15e-07	3.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—breast cancer	7.1e-07	3.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—breast cancer	6.6e-07	3.33e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CA—breast cancer	6.3e-07	3.18e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—breast cancer	5.14e-07	2.59e-06	CbGpPWpGaD
